Approved Hospital Formulary
QR Code Add Formweb to your mobile device

Formulary synchronization in progress.
Please refer to Epic and your local pharmacy for available medications.

Approved Hospital Formulary
Search results for:

pegfilgrastim

pegfilgrastim
Brand names: Fulphila (biosimilar), Neulasta (originator product), Neulasta Onpro Kit including On Body Injector (originator product), Nyvepria, Udenyca (biosimilar), Ziextenzo (biosimilar)
Form Strength
INJECTION, SUBCUTANEOUS 6 mg/0.6 mL; 6 mg/0.6mL
SOLUTION, SUBCUTANEOUS 6 mg/0.6 mL


Consults, protocols, and therapeutic interchanges

 

Additional information

Houston Methodist medication policy denotes Neulasta as the preferred pegfilgrastim product. Udenyca is the preferred biosimilar product if the third party payor will only cover a biosimilar. Preferred products are first-line preferred agents for use, however, alternative product selection is permitted if mandated by third party payor coverage. 

 


Last updated: May. 8, 2020


This site is intended for the staff of Houston Methodist.
While others may view accessible pages, Houston Methodist makes no warranty, express or implied,
as to the use of this information outside of Houston Methodist.